Feed / COO

The Cooper Companies, Inc.

COO

Healthcare · 53.89 -0.6% today

Isolated · not yet confirmedMarket checked 11 Sept, 15:55 GMT-4

Market read

The Cooper Companies, Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 20 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 10 directly disclosed connections are confirming.

Company-0.6% todayVolume comparison unavailable
Market group0 of 20 activeMedical Devices · unavailable
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • COO's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if COO's group or a disclosed connection begins moving with it.

Watch this read

Research brief

The story so far

Healthcare · Medical Instruments & Supplies

No new filing conclusion is available. 0 of 20 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 10 directly disclosed connections are confirming.

Evidence that supports

No thresholded supportive filing evidence is available yet.

Evidence that challenges

No thresholded adverse filing evidence is available yet.

What would clarify the read
  • COO's market-adjusted activity becomes unusual and at least one connected name confirms.

Company research

Understand the business, not just the ticker

As of Sep 12, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods9
Price observations602
Usable filing statements31
Verified relationships11
Evidence supporting the case
  • Latest annual revenue changed +5.1% year over year.
  • Operating cash flow covered net income at 2.12x in the latest annual period.
Evidence challenging the case
  • Operating margin changed -1.4 percentage points in the latest annual period.
Questions before a position
  • P/E is 99% below the available filing-peer median; determine whether growth and quality justify the difference.
  • EV/sales is 16% above the available filing-peer median; determine whether growth and quality justify the difference.
Longer-term price context

Price as of Sep 11, 2026

53.89
6m-24.7%12m-20.4%24m-49.5%
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2021-10-31$2.9B+20.2%$59.16+0.4%
2022-10-31$3.3B+13.2%$1.94
2023-10-31$3.6B+8.6%$1.48+0.3%
2024-10-31$3.9B+8.4%$1.96+0.6%
2025-10-31$4.1B+5.1%$1.87-0.2%

What management says matters

Persistent and emerging business drivers

Legal and regulatory exposurepositive · 3 filings
For the nine months ended July 31, 2026, the net impact to the consolidated statements of operations to resolve outstanding claims was $272.0 million, consisting of $325.8 million accrued litigation liability, partially offset by $53.8 million of insurance re…
10-Q · Sep 9, 2026
Credit and interest ratesnegative · 1 filings
Cash provided by financing activities in fiscal 2024 was primarily attributable to funds received from the 2024 Revolving Credit Facility, partially offset by repayments to fully repay all borrowings outstanding under the 2020 Term Loan Facility and the 2020…
10-K · Dec 5, 2025
Foreign exchangemixed · 1 filings
Other Expense, Net ($ in millions) 2025 2024 Foreign exchange loss $ 8.0 $ 5.2 Other expense, net 8.4 3.9 $ 16.4 $ 9.1 Foreign exchange loss was primarily due to movements of U.S.
10-K · Dec 5, 2025
Pricing and mixmixed · 1 filings
As a result of these competitive forces, we believe there will continue to be pricing pressure in the future.
10-K · Dec 5, 2025

Valuation discipline

Descriptive valuation snapshot

Price/sales 2.6× · EV/sales 3.2×. Comparisons use only industry-matched filing peers.

Scenario scaffold

Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.

Price action

How the market is pricing the story

53.89-0.6% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for COO. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Filing analysis

No comparable filing assessment is available yet

Jodie has not yet found a suitable current-versus-prior filing comparison for COO. This does not mean the latest filing was neutral or immaterial.

Business ecosystem

The relationships behind COO

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

ABBVAbbVie Inc.competitorDec 5, 2025

With Paragard, we compete with manufacturers of hormonal IUDs including Bayer and AbbVie, Long Acting Reversible Contraceptives including Organon, and other forms of birth control.

ALCAlcon Inc.competitorDec 5, 2025

CooperVision Competition CooperVision competes in the spherical, toric and multifocal lens categories of the contact lens worldwide market against Johnson & Johnson Vision Care, Inc., Alcon Inc., Bausch + Lomb as well as other smaller companies with limited p…

Depended on by

FGF&G Annuities & Life, Inc.customerFeb 26, 2026

Cooper also alleges that he is a F&G customer and brings similar common law tort claims and alleges claims as a purported third-party beneficiary of an alleged contract.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 8 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

COO is currently a Follower in the organic co-movement group Medical Devices. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.